معرفی
Dr. Kym Carter serves as a Senior Research Officer at the Swansea Trials Unit within Swansea University's School of Medicine. Based at the Institute of Life Science 1 on Singleton Campus, Dr. Carter specializes in clinical trial management across various medical specialties including gastroenterology, cancer, diabetes, trauma, and dermatology. With over two decades of research experience since 1999, Dr. Carter has progressed from initial work with the Welsh Blood Service examining hemochromatosis to leading health services research at Swansea University.
Dr. Carter's research interests span clinical trial management, observational studies, health services research, data analysis, and Patient and Public Involvement. Their work demonstrates particular expertise in designing and managing complex clinical trials across multiple therapeutic areas, with a focus on methodological rigor and practical implementation in real-world healthcare settings. The research portfolio shows consistent engagement with large-scale record linkage studies, systematic reviews, and randomized controlled trials across European healthcare systems.
Analysis of Dr. Carter's recent publications reveals a strong focus on clinical trials methodology, particularly in diabetes research (with multiple studies on ustekinumab for type 1 diabetes), healthcare worker well-being during the pandemic, trauma outcomes, and social determinants of health. The work spans diverse medical specialties while maintaining a consistent methodological approach to clinical research design and implementation.
Dr. Carter is actively involved in postgraduate supervision and has contributed to numerous significant research projects through the Swansea Trials Unit. Their collaborative work involves multidisciplinary teams across multiple institutions and countries, reflecting the collaborative nature of modern clinical research. The research has been published in high-impact journals including Nature Medicine, The Lancet, and BMJ Open.
